Sunstone Therapies hosted an Open House, offering providers an opportunity to tour the first purpose-built center designed to deliver psychedelic-assisted therapy in a medical setting, meet the physician-led research team, and learn about the FDA approved clinical trials we are running. The evening included remarks from Sunstone’s CEO, Dr. Manish Agrawal, and Psychiatrist Dr. Rajan Dunne.
July 28, 2025 | Join us to explore the nuances of delivering psychedelic therapy within clinical trial protocols and clinical settings.
June 10, 2025 | An in person clinic visit to meet our clinical team, explore our ongoing clinical trials for complex mental health conditions, and learn more about the care we provide in our purpose built center for psychedelic-assisted therapy.
May 20, 2025 | This webinar explored the critical role of preparation visits in supporting patients through psychedelic therapy clinical trials.